small molecule

LEVONORGESTREL

LEVONORGESTREL

Loss of exclusivityloss of exclusivity
CompanyLABORATOIRE HRA PHARMA

Drug detail

Brand nameLEVONORGESTREL
Active ingredientLEVONORGESTREL
Strength1.5MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2018
Marketing statusOTC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

LEVONORGESTREL patent cliff — loss of exclusivity — | CliffBio